Positron Emission Tomography/Computed Tomography in Colorectal Cancer
PET/CT for colorectal cancer is whole-body imaging technique and qualitative diagnosis with high sensitivity and specificity in comparison to other modalities. In the diagnosis of the degree of the primary lesion by PET/CT, it is possible to diagnose the
- PDF / 10,056,731 Bytes
- 147 Pages / 439.43 x 683.15 pts Page_size
- 58 Downloads / 259 Views
123
Applications of FDG PET in Oncology
Hirofumi Fujii • Hiroyuki Nakamura Seiei Yasuda Editors
Applications of FDG PET in Oncology Best Clinical Practice
Editors Hirofumi Fujii Division of Functional Imaging, Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Chiba Japan
Hiroyuki Nakamura Department of Respiratory Medicine Tokyo Medical University Ibaraki Medical Center Ibaraki Japan
Seiei Yasuda Chairman of the board of trustee Yotsuya Medical Cube Tokyo Japan
ISBN 978-981-15-8422-0 ISBN 978-981-15-8423-7 (eBook) https://doi.org/10.1007/978-981-15-8423-7 © Springer Nature Singapore Pte Ltd. 2021 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Singapore Pte Ltd. The registered company address is: 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore
Preface
Although cancer is still the leading cause of death in many countries, recent epoch- making advance in molecular biology facilitates to reveal the nature of cancer at the level of gene and the era of “precision medicine” has come. New therapeutic strategies for cancer are established based on these genomic information. In response to this progress in cancer treatment, the concept of molecular imaging has also been introduced in the field of diagnostic imaging sciences. Nuclear medicine tests that can evaluate the functional features of lesions would be clinical molecular imaging tests. Among them, F-18 FDG PET tests that can provide metabolic activity of glucose in tissues including cancer lesions are attracting a strong attention in oncology. Many research works in the field of nuclear medicine have demonstrated the usefulness of FDG PET tests in clinical oncology. However, FDG PET tests have not been so familiar in routine clinical practice in many countries
Data Loading...
